Cervix Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-07
Clinical Trial Update: Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide [Phase 1, Phase 2]
Phase 1/Phase 2 trial update for Combidex USPIO in uterine and cervical neoplasms, completed.